The first stop for professional medicines advice

Intrathecal medicines

32 results

Applied filters

Pharmacy Intrathecal Chemotherapy Audit Aide Memoire 4th Edition (Yellow Cover)

24 May 2010This audit document is intended to be used to audit Pharmacy aspects of the safe administration of intrathecal chemotherapy, as part of the EL(97)52 Audit…

Omnipaque: informing intrathecal risk assessment

11 August 2022Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Morphine: informing intrathecal risk assessment

11 August 2022Morphine sulfate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Methotrexate: informing intrathecal risk assessment

11 August 2022Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Managing an intrathecal chemotherapy service

13 June 2025The intrathecal route is a high-risk route of administration. There are minimum requirements for providing intrathecal chemotherapy.

Lidocaine: informing intrathecal risk assessment

11 August 2022Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Levobupivacaine: informing intrathecal risk assessment

11 August 2022Levobupivacaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Intrathecal administration

All our advice on using intrathecal medicines safely.

Hydromorphone: informing intrathecal risk assessment

11 August 2022Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone: informing intrathecal risk assessment

11 August 2022Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration